Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

European Countries Issue Alzheimer’s Biomarker Warning

Jul 01 2021

• By Francesca Bruce

Alzheimer's PET scan — HTA Alzheimer's endpoints are under the microscope in Europe

Related Content

European Countries Should Join Forces To Lower Prices of Zolgensma & Kaftrio

May 19 2021

BeNeLuxA Makes First Positive Reimbursement Decision On Biogen’s Spinraza

Jul 19 2018

Strength in Numbers: EU Cross-Country Drug Pricing Coalitions Join Forces

Jun 09 2021

Aducanumab Accelerated Approval Reflects US FDA Flexibility But Raises Doubts About Confirmatory Trial

Jun 08 2021

Biogen Gets ‘Almost Shockingly Broad’ Label For Alzheimer’s Drug Aducanumab

Jun 08 2021

Related Companies

Biogen, Inc.

Eisai Co., Ltd.

Additional Topics

Europe Health Technology Assessment Market Access Regulation Pricing Debate Policy Neurology BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window